Economic model created for CDC shows that in older adults promoting updated vaccination will save the US money, while in other adults it should be reasonably cost effective.
Weiser Professional Development Fellow visits Michigan Public Health, reconnects with longtime collaborator
Bosiljka Djikanovic visited as part of Ronald and Eileen Weiser Center for Europe and Eurasia program
Earlier this year, Serbian professor and public health researcher Bosiljka Djikanovic visited the University of Michigan School of Public Health as part of a faculty development program hosted by the Weiser Center for Europe and Eurasia.
Arnold Monto quoted in Stat
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.
Q&A with David Hutton
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Matthew Boulton featured in Detroit Free Press
Matthew Boulton, Senior Associate Dean for Global Public Health, was quoted in Detroit Free Press. He stated it is important for the public to be updated with their polio vaccines.
New research from Abram L. Wagner
Identifying adults who are ambivalent about vaccines early in a pandemic and finding community leaders who can help spread reliable information within their communities could help reduce vaccine hesitancy, according to a new University of Michigan study.